As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
Mass Device sister publication Drug Delivery Business News reported recently that Clearside Bio, a GCMI client, “has enrolled the first patient in a Phase III trial evaluating its eye drug combined with an intravitreally-administered anti-VEGF agent as a treatment for macular edema associated with retinal vein occlusion.” Reporter Sarah Faulkner goes on to write, “The…
In GCMI’s experience, the decision to commit to a design and development plan for a new medical product should not be understated in its significance. Prior to making this commitment of time, money, energy and focus, an innovator must truly understand the tasks ahead of them, what the finish line looks like, how long it…
An estimated 10 million Americans suffer from atrial fibrillation (AF). The current medications to treat AF have low success rates and potentially toxic side effects. With preclinical help from T3 Labs and the support of experts within the Atlanta medtech ecosystem, Dr. Rebecca Levit aims to change that. Dr. Levit is Assistant Professor of Cardiology…
In medical product development, correctly identifying and committing to your FDA approval process or pathway can make or break many new projects.
GCMI-T3 Labs will be exhibiting at the Society of Interventional Radiology annual meeting (Booth 833), which will be held March 17-22, 2018 in sunny Los Angeles, CA. This is a great opportunity to learn about the latest clinical and scientific contributions as well as current treatments, needs and future trends in interventional radiology. We look…
Connect with T3 Labs at AAOS 2018 The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of thought leaders, physicians, scientists and academics seeking the latest in injury prevention and disease treatment of the musculoskeletal system. AAOS 2018 will bring the top names in…
Dear customers, vendors, colleagues and friends, It is with great pleasure that we announce our newly integrated and rebranded GCMI website, www.gcmiatl.com. This new website gives a comprehensive look at all our service lines: Design & Development Preclinical Testing and Bioskills Training Lifecycle Advisory This website and our new organizational look and feel is a result…
The American Cancer Society (ACS) is partnering with the Atlanta-based Global Center for Medical Innovation (GCMI) to more rapidly bring groundbreaking research from the lab to the clinic. The American Cancer Society conducts research and funds research through grants to hundreds of scientists and health professionals nationwide. Bridging the gap between early research and actual…
Venture Summit West 2018 – Where Innovation Meets Capital March 13th – 14th, 2018 | Santa Clara Convention Center | Silicon Valley Friends, GCMI is pleased to announce its sponsorship and invite you to attend Venture Summit West 2018. Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, Venture Summit | West presented by youngStartup Ventures is one event you won’t want to miss.…
A new medical device’s or product’s pathway from concept to cure to commercialization is fraught with pitfalls, setbacks and usually significant financial investment. T3 Labs prides itself in delivering value-based excellence in what we consider phase 2 of this process, preclinical testing. We are often asked by prospective sponsors for in vivo preclinical studies that…